Dao Tian Fu
No más puestos en curso
Perfil
En la actualidad, Dao Tian Fu ocupa el cargo de Presidente de RemeGen Co. Ltd. Anteriormente, el Dr. Fu fue director de control de calidad e investigación en Neose Pharmaceuticals, Inc., director ejecutivo y vicepresidente de Livzon Pharmaceutical Group, Inc. y director general de Livzon MABPharm Inc. (una filial de Livzon Pharmaceutical Group, Inc.), Vicepresidente de Investigación en Genzyme Corp. y Director de la División de Medicina Interna en REVO Biologics, Inc. Se doctoró en la Universidad Estatal de Iowa y se licenció en la Universidad de Shandong.
Antiguos cargos conocidos de Dao Tian Fu.
Empresas | Cargo | Fin |
---|---|---|
REMEGEN CO., LTD. | President | 12/05/2023 |
LIVZON PHARMACEUTICAL GROUP INC. | Director/Board Member | 27/09/2019 |
Livzon MABPharm Inc.
Livzon MABPharm Inc. Pharmaceuticals: MajorHealth Technology Part of ZHU HAI Livzon Biologics Ltd., Livzon MABPharm Inc. researches, develops, and sells biopharmaceutical products and antibody drugs. The private company is based in Zhuhai, China. | Chief Executive Officer | 01/09/2019 |
EPIRUS BIOPHARMACEUTICALS, INC. | Director/Board Member | 25/07/2016 |
REVO BIOLOGICS INC | Corporate Officer/Principal | 01/01/2001 |
Formación de Dao Tian Fu.
Iowa State University | Doctorate Degree |
Shandong University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
LIVZON PHARMACEUTICAL GROUP INC. | Health Technology |
LUNGLIFE AI, INC. | Health Services |
EPIRUS BIOPHARMACEUTICALS, INC. | Health Technology |
REMEGEN CO., LTD. | Health Technology |
Empresas privadas | 5 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Neose Pharmaceuticals, Inc. | |
rEVO Biologics, Inc.
rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
Livzon MABPharm Inc.
Livzon MABPharm Inc. Pharmaceuticals: MajorHealth Technology Part of ZHU HAI Livzon Biologics Ltd., Livzon MABPharm Inc. researches, develops, and sells biopharmaceutical products and antibody drugs. The private company is based in Zhuhai, China. | Health Technology |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Dao Tian Fu